
|Videos|August 24, 2021
42-Year-Old Female With Itchy Eyes
This program is sponsored by Eyevance Pharmaceuticals, a Santen company.
Advertisement
Mark S. Milner, MD
Board-certified Ophthalmologist
Associate Clinical Professor, Yale University School of Medicine,
New Haven, Connecticut
Director of Cornea, Goldman Eye, Palm Beach Gardens, Florida
Co-Chief Medical Officer, Eyevance Pharmaceuticals, a Santen company
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approvals in 2025: What changed and why it matters for ophthalmologists
2
PRIMAvera study: Central vision improvement with subretinal implant
3
Achieving a new level of refractive precision: Surgical strategies
4
The year in optometry: 10 stories that defined eye care in 2025
5

